Cowen and Company’s CVS Health CVS Stock Holding History

Cowen and Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$17K	–	445
2020 Q2	$17K	Buy	+10,000	New	+$630K	﹤0.01%	344

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cowen and Company's CVS Position: Q1 2023 in Review

Cowen and Company sold out of CVS Health (CVS) in Q1 2023, closing a stake of 3,181 shares — an estimated $296K sold.

Cowen and Company first reported a position in CVS in Q1 2020 and held it in 5 quarters. The position peaked at $4.54M in Q1 2020. 2,269 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Cowen and Company reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Cowen and Company sold 3,181 CVS Health shares in Q1 2023, an estimated $296K.
Cowen and Company first reported a position in CVS Health in Q1 2020 and held it in 5 quarters.
Cowen and Company's CVS Health position peaked at $4.54M in Q1 2020.
2,269 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.